Experts shared the latest information on emerging CLL research and clinical trials, including news from the 2022 American Society of Hematology (ASH) annual conference and responded to audience questions.
Expert Panel:
Dr. Michael Keating, Founder, CLL Global Research Foundation
Dr. William Wierda, President & CEO, CLL Global Research Foundation
Dr. Nitin Jain, Associate Professor in the Department of Leukemia, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center
Jeff Folloder, Moderator and CLL patient advocate
